FDA Accepts Premarket Approval Application for Tumor Treating Fields Therapy for Non-Small Cell Lung Cancer

Novocure’s tumor-treating fields plus standard-of-care therapies is under evaluation in patients with non-small cell lung cancer following disease progression on or after platinum-based treatment.

Source link
#FDA #Accepts #Premarket #Approval #Application #Tumor #Treating #Fields #Therapy #NonSmall #Cell #Lung #Cancer